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Abstract Low-level laser (light) therapy (LLLT) has been
applied over skeletal muscles before intense exercise
(muscular pre-conditioning) in order to reduce fatigue and
muscle damage (measured by creatine kinase, CK) in clinical
trials. However, previous exercise protocols do not exactly
simulate the real muscle demand required in sports. For this
reason, the aim of this randomized and double-blind placebo-
controlled trial was to investigate whether light-emitting diode
therapy (LEDT) applied over the quadriceps femoris muscles,
hamstrings, and triceps surae of volleyball players before
official matches could prevent muscle damage (CK) with a
dose response, establishing a therapeutic window. A profes-
sional male volleyball team (12 athletes) was enrolled in this
study, and LEDT was applied before 4 matches during a na-
tional championship. LEDT used an array of 200 light-
emitting diodes (LEDs) arranged in 25 clusters of 4 infrared
LEDs (850±20 nm; 130 mW) and 25 clusters of 4 red LEDs
(630±10 nm; 80 mW). Athletes were randomized to receive
one of four different total doses over each muscle group in a
double-blind protocol: 105 J (20 s), 210 J (40 s), 315 J (60 s),
and placebo (no light for 30 s). CK in blood was assessed 1 h
before and 24 h after each match. LEDT at 210 J avoided
significant increases in CK (+10 %; P=0.993) as well as
315 J (+31 %, P=0.407). Placebo (0 J) allowed a significant
increase in CK (+53%; P=0.012) as well as LEDTat 105 J (+
59%; P=0.001). LEDT prevented significant increases of CK
in blood in athletes when applied before official matches with
a light dose response of 210–315 J, suggesting athletes might
consider applying LEDT before competition.
Keywords Photobiomodulation . LLLT . CK .Muscle
damage . Exercise recovery .Muscle performance
Introduction
The benefits of low-level laser (light) therapy (LLLT) to treat
pain [1, 2], tendinopathies [3] and to promote tissue healing
[2, 4] have been investigated for several years. The mecha-
nism of the light-tissue interaction is thought to involve cyto-
chrome c oxidase (Cox) as the main chromophore in the cells
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able to absorb specific wavelengths of light [5–9]. Cox is a
mitochondrial enzyme with a very important function in the
electron transport chain and consequently promotes cell res-
piration and energy production in the form of adenosine tri-
phosphate (ATP). For these reasons, LLLT has been widely
used for several types of medical treatment, especially those
indications that require stimulation of cells and improved
healing.
Recently, LLLT has been used to increase muscle perfor-
mance [10, 11]. When applied after exercise, LLLT promoted
reduction of fatigue [12] and increased the workload in max-
imum effort tests [13] after training programs. When applied
before the exercise (muscular pre-conditioning), LLLT in-
creased the number of repetitions and was able to promote
Bmuscle protection^ against exercise-induced muscle damage
[10, 11] measured by a lower increase of creatine kinase (CK)
levels in the blood. In this context, it is valuable to highlight
that CK is an important enzyme of the energy metabolism
located inside muscle cells, but its increase in the bloodstream
after a bout of exercise is an indicative of rupture of muscle
cell membrane and consequently muscle damage [14].
In order to investigate the effects of LLLT on Bmuscle
protection^ against exercise-induced muscle damage, differ-
ent protocols of exercise or neuromuscular electrical stimula-
tion have been used to induce muscle fatigue and damage in
experimental models [15–20] and in clinical trials [21–28].
These studies have evaluated different wavelengths and dif-
ferent light sources such as diode lasers and light-emitting
diodes (LEDs) [29]. Three recent studies [10, 11, 30] reported
fascinating results and point to the effectiveness of muscular
pre-conditioning using diode lasers and LEDs to prevent mus-
cle fatigue and muscle damage (CK) when applied before
(5 min) a bout of exercise.
Having in mind all previous results for muscular pre-
conditioning [10, 11, 30], the present study aimed to inves-
tigate the effectiveness of the LLLT by LED therapy
(LEDT) in the prevention of muscle damage (CK) in pro-
fessional volleyball players during a national champion-
ship. This randomized double-blind placebo-controlled
study used an array of LEDs to irradiate equally all target
muscle groups [13] with different doses of light in order to
establish also a therapeutic window or dose response [31]
for LEDT, thus translating these studies to clinical practice.
Moreover, the LED array emitted red and infrared light at
the same time based on studies that reported better absorp-
tion of the light by Cox using bandwidths in the red and
near-infrared spectral regions [5–9]. The possible time re-
sponse of 5 min widely reported in muscular pre-
conditioning [10, 11, 30] was modified to 40–60 min, since
previous studies already reported a range of 3–45 min for
LLLT to increase ATP synthesis in cells [32, 33], and also
made it possible to perform muscular pre-conditioning for
all athletes before each official volleyball match.
Materials and methods
Study design and ethics statement
The present study was a randomized, double-blind, and
placebo-controlled trial involving a professional team of vol-
leyball players in the BSuperliga^ (national championship) in
Brazil during four official matches. Each match was carried
out in different stadiums, in accordance with the champion-
ship schedule. All researchers traveled with the coaching staff
and volleyball players during the study. This study was con-
ducted in compliance with the Declaration of Helsinki (1964)
and its later amendments, and also approved by the Research
Ethics Committee for Human Studies of the Federal Univer-
sity of Sao Carlos (number protocol approved 217/2012).
Volunteers
Twelve professional volleyball players (the whole team) were
enrolled in the study. They had an average age of 25.5±
5.3 years old, body weight of 90.6±7.3 kg, and height of
200±8.7 cm. After their agreement, all players signed the
informed consent statement.
Inclusion criteria and exclusion criteria
Inclusion criterion used was healthy professional volleyball
players. Exclusion criterion used was volleyball players hav-
ing musculoskeletal injuries prior to the study or injured dur-
ing the course of the study.
Groups and randomization procedures
All athletes were randomly allocated into four different groups
for muscular pre-conditioning in accordance with the assigned
light dose (Joules, J) of the light-emitting diode therapy
(LEDT):
& Dose 1—20 s of real LEDT (105 J total) over quadriceps
femoris muscles, hamstrings, and triceps surae
& Dose 2—40 s of real LEDT (210 J total) over quadriceps
femoris muscles, hamstrings, and triceps surae
& Dose 3—60 s of real LEDT (315 J total) over quadriceps
femoris muscles, hamstrings, and triceps surae
& Dose 4—30 s of placebo LEDT (0 J total) over quadriceps
femoris muscles, hamstrings, and triceps surae
Each athlete randomly received one of the light doses
before each one of the four official matches of the cham-
pionship. The randomization procedure was conducted at
Randomization.com (http://www.randomization.com)
using balanced permutations into one block with four
different therapies: dose 1 to dose 4. The randomization
procedure was carried out by evaluator #1 that operated
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the LED device. This researcher was instructed not to
inform athletes, researchers, and coaching staff which
dose was applied to each athlete at each match.
During the course of the study, two athletes suffered
musculoskeletal injuries and then were excluded. One
athlete belonged to dose 4 (30 s of irradiation—placebo)
and the second athlete belonged to dose 2 (20 s of
irradiation). However, these exclusions did not affect the
number of subjects per group once all statistical analyses
were performed using data of all the six principal active
players (not reserve players) in each match.
Experimental protocol
Light-emitting diode therapy
LEDT used a flexible array of 34×18 cm (612 cm2) similar to
the one used in a previous study developed by our research
group [34]. However, this prototype device has 200 LEDs ar-
ranged in 25 clusters of four infrared LEDs (850±20 nm;
130 mW) and 25 clusters of four red LEDs (630±10 nm;
80 mW) displayed at five lines of ten clusters. Each line has
one infrared cluster interspersed by one red cluster, totaling five
infrared clusters plus five red clusters per line. Irradiation lasted
20, 40, 60, or 30 s (placebo) over each muscle group (quadri-
ceps femoris, hamstrings, triceps surae) of each athlete’s leg
with fixed parameters as described in Table 1. Real LEDT or
placebo was applied between 40 and 60 min before the start of
each official match, in accordance with randomization proce-
dures. LEDT placebo had no energy (0 J) and no power
(0 mW) applied over these muscle groups. Optical power was
measured with an optical energy meter PM100D Thorlabs®
fitted with a sensor S130C (area of 0.70 cm2). All athletes were
blinded for these therapies as well as the coaching staff and
evaluator #2 until the end of the study. There was no percepti-
ble sensation of heat to the skin from real LEDT.
Blood samples for creatine kinase activity
Blood samples for creatine kinase activity measurement were
collected by puncturing the athlete’s ear lobe using sterile
lancets 1 h before and 24 h after each official match. The
puncture site was cleaned with alcohol and dried, and the first
drop of blood was discarded. The blood collected (30 μL) was
immediately analyzed with Reflotron Plus® biochemical ana-
lyzer (Roche, Germany) [14] following the manufacturer’s
guidelines. This analysis was conducted by evaluator #2,
and all results were blinded for evaluator #1, athletes, and
coaching staff until the end of the study.
Matches
The time of each match was monitored by evaluator #3
(coaching staff) as well as which were the six active players
in each match (not reserve players).
Table 1 Parameters of light-
emitting diode therapy (LEDT) Number of LEDs 200 (100 infrared-IR and 100 red-RED)
Wavelength 850±20 nm (IR) and 630±10 nm (RED)
Number of clusters 25 (IR) and 25 (RED)
Frequency Continuous output
Optical output (each cluster of 4 LEDs) 130 mW (IR) and 80 mW (RED)
Total optical output 5250 mW (25×130 mW plus 25×80 mW)
LED spot size (cm2) 0.2
Power density (each cluster) 185.74 mW/cm2 (IR) e 114.28 mW/cm2 (RED)
Treatment time over each muscle group (s) 20, 40, or 60
Energy per cluster at 20 s 2.6 J (IR) and 1.6 J (RED)
Energy per cluster at 40 s 5.2 J (IR) and 3.2 J (RED)
Energy per cluster at 60 s 7.8 J (IR) and 4.8 J (RED)
Energy density per cluster at 20 s 3.71 J/cm2 (IR) and 2.28 J/cm2 (RED)
Energy density per cluster at 40 s 7.42 J/cm2 (IR) and 4.56 J/cm2 (RED)
Energy density per cluster at 60 s 11.13 J/cm2 (IR) and 6.84 J/cm2 (RED)
Total energy delivered per muscle group at 20 s 105 J [2.6 J×25=65 J (IR) plus 1.6×25=40 J (RED)]
Total energy delivered per muscle group at 40 s 210 J [5.2 J×25=130 J (IR) plus 3.2×25=80 J (RED)]
Total energy delivered per muscle group at 60 s 315 J [7.8 J×25=195 J (IR) plus 4.8×25=120 J (RED)]
Total energy delivered on body (J) 630
Total energy delivered on body (J) 1260
Total energy delivered on body (J) 1890
Application mode Device held coupled in skin contact
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Statistical analysis
Although this study enrolled a whole team (12 athletes), and all
athletes received one of the light doses before each match, the
statistical analysis was applied to the six principal active
players (not reserve players) in each match. Thus, each group
(light dose) had 6 subjects, and the study had a total sample size
of 24 subjects. Shapiro-Wilk’s W test verified the normality of
the data distribution. Creatine kinase activity among all groups
was compared using two-way analysis of variance (ANOVA)
with repeatedmeasures and Tukey honest significant difference
(HSD) post hoc test. Significance was set at P<0.05.
Results
Matches
The average time of the matches was 133.75±8.99 min.
Creatine kinase activity
All results of CK activity were presented as mean ± standard
deviation (SD). LEDT dose 1 (20 s, 105 J) allowed a signifi-
cant mean increase in CK (from 328.0±188.9 to 499.6±
232.0 U/L; +59 %; P=0.001). Dose 4 (30 s—placebo, 0 J)
also allowed a significant increase in CK (from 270.3±112.4
to 406.1±150.5 U/L; +53 %; P=0.012). However, LEDT
dose 2 (40 s, 210 J) avoided a significant increase in CK (from
338.8±130.3 to 364.1±127.5 U/L; +10 %; P=0.993). Dose 3
(60 s, 315 J) also prevented a significant increase in CK (from
245.1±126.9 to 318.0±153.5 U/L; +31 %; P=0.407). These
results were measured in all six principal active players of
each match and presented in Fig. 1.
Discussion
This study investigated the dose response of light-emitting di-
ode therapy to prevent significant increases in creatine kinase
activity in volleyball players during official matches, establish-
ing a Btherapeutic window^ (dose response of different doses
of light). We applied LEDT on lower limb muscles aiming to
cover the major muscle groups involved in jumping and land-
ing movements that are required during volleyball matches.
Moreover, the array of LEDs used in this study covered the
entire target muscle groups as has been previously recommend-
ed by our research group [13]. To our knowledge, this is the
first study that applied LEDT on muscles of professional ath-
letes before official matches to prevent muscle damage.
The effects of low-level laser (light) therapy on muscle
tissue when applied before or after intense exercise are mainly
related to the prevention of exercise-induced damage, promo-
tion of faster muscle recovery, and also producing increases in
performance [10, 30, 11]. The use of LLLT to prevent muscle
damage has been widely investigated in experimental models
[15–20] and in clinical trials [21–28]. Experimental studies
have used animal models to induce muscle damage, and clin-
ical trials have used protocols of exercise in isokinetic dyna-
mometers, fitness machines, or free weight lifting to induce
muscle damage. However, all these studies could not exactly
simulate the real muscular demand in athletes during official
matches of any sport, motivating our research group to inves-
tigate the effectiveness of LEDT in volleyball players using a
regimen of muscular pre-conditioning to prevent increases in
CK.
Previous studies already reported benefits of the LLLT
using diode lasers and LEDs to prevent increases in CK ac-
tivity [10, 30, 11]. To our knowledge, the first study that used
LLLT to prevent muscle damage was carried out by Lopes-
Martins et al. [15] in an experimental animal model. These
authors investigated the effects of different doses of light (0.5;
1.0 and 2.5 J/cm2) in muscular pre-conditioning to prevent
muscle fatigue and muscle damage (CK) induced by neuro-
muscular electrical stimulation. These authors reported a
LLLT dose response to decrease CK activity in muscle tissue.
Another experimental study trained rats on an inclined tread-
mill and measured inhibition of inflammation, reduction of
CK ac t i v i t y, and lower ing of ox ida t i ve s t r e s s
(malondialdehyde, MDA). They also found increases in
Fig. 1 Mean and standard
deviation (SD) for creatine kinase
activity (CK) in blood pre and
post each official match between
groups. LEDT light-emitting
diode therapy; asterisk represents
statistical significance (P<0.05)
in two-way analysis of variance
(ANOVA) with repeated
measures and Tukey HSD post
hoc test
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defense against oxidative stress (increased activity of super-
oxide dismutase, SOD) 24 and 48 h after exercise [16]. These
studies were important to demonstrate the benefits of LLLTon
exercise-induced muscle damage, inflammation, and oxida-
tive stress.
More studies using experimental models were conducted to
investigate the effects of LLLTon CK activity [18, 17, 19, 20].
Using a similar model of neuromuscular electrical stimulation
previously reported [15], other studies also found LLLT dose
responses of muscular pre-conditioning by decreased CK ac-
tivity [18, 19], including assessment of different wavelengths
[20]. Another study observed a reduction in CK activity when
LLLT was applied after exercises in a model of swimming
with workload [17]. Recently, LLLT using LEDs (LEDT)
has demonstrated similar benefits to decrease CK activity
when applied after exercise [35] or during rest intervals be-
tween bouts of physical activity [36]. All these studies
assessed CK activity after 24 h or during a time range of
24–48 h after the exercise.
These aforementioned experimental studies created the sci-
entific basis for the use of the LLLT, including LEDT, in
prospective clinical trials that aimed to prevent exercise-
induced muscle damage by assessing CK activity. Recently,
this effect of Bmuscle protection^ by LLLT has been observed
in humans using different exercises protocols for the upper
and lower limbs [10, 11, 30]. These studies reported lower
increases in CK activity measured in blood when LLLT was
applied before intense exercises. Light doses (Joules, J) used
in previous studies were between 1 and 6 J delivered per diode
laser, totaling 4 J [21] or 60 J [22] delivered to the biceps
brachii; 30 and 40 J [23] or 180 J [24] delivered to the quad-
riceps femoris muscles.When the light source was LED, these
studies used a cluster of 69 LEDs and applied 0.3 or 0.9 J per
LED, totaling 41.7 J per site of irradiation and a total dose of
41.7 J delivered on biceps brachii [25]; 83.4 J [26] or 125.1 J
[27] or 208.5 J [28] delivered to quadriceps femoris muscles.
Our results are in accordance with the total dose used in
previous studies that used LEDs (LEDT) or combined LEDs
and super-pulsed lasers to prevent increases in CK activity in
the quadriceps femoris muscles with total doses from 60 to
300 J [29]. Our effective total doses of LEDT were 210 J
[130 J (IR) plus 80 J (RED)—40 s of irradiation] and 315 J
[195 J (IR) plus 120 J (RED)—60 s of irradiation] as reported
similarly by a previous study [29]. LEDT placebo and the total
dose of 105 J [(65 J (IR) plus 40 J (RED)—20 s of irradiation]
allowed a significant increase of CK activity, indicating po-
tential muscle damage and failure of the LEDT to promote
Bmuscle protection.^ In addition, we chose to use dual wave-
lengths (red and near-infrared at the same time) based on spe-
cific absorption bands of cytochrome c oxidase (Cox) [5–9]
that is the main chromophore in the cells. Moreover, our re-
sults were observed using muscular pre-conditioning applied
40–60 min before the start of each official match. This
consideration is important because the waiting time can allow
the muscles more time to respond to the light and could
change the accepted paradigm that muscular pre-
conditioning using LLLT for the prevention of exercise-
induced muscle damage should be applied 5 min before the
exercise.
The optimum doses of light delivered from each cluster of
four LEDs were between 5.2 and 7.8 J for infrared and be-
tween 3.2 and 4.8 J for red. These energy doses are similar to
doses emitted by diode lasers in a previous study [24], rein-
forcing the idea that light is light [37] and there is not a large
difference between these light sources to prevent exercise-
induced muscle damage (CK) if the total dose applied per
muscle group is adequate. However, it is important to remark
that it is possible that the light dose used to prevent muscle
damage with LEDT in a pre-conditioning regimen may not be
the same dose necessary if the light therapy is applied after the
exercise [38]. It is accepted that cells under biochemical or
mechanical stress have better responses to light [39] than cells
in homeostasis.
The number of jumps and landings or of any other move-
ment performed by each athlete during each match was not
equal and could not be standardized among the six principal
active players. This could be understood as a limitation, but
the course of each match was unpredictable and could not be
standardized.
Finally, the present study was not designed to elucidate the
mechanisms of action of LEDT when used in muscular pre-
conditioning to prevent exercise-induced muscle damage.
However, previous studies reported better defenses against
oxidative stress [16] if LLLT is applied over muscles after
intense exercises as well as before exercise as reported in a
previous clinical trial [40]. As mentioned above, the main
chromophore, or red/NIR light-sensitive protein, present in
biological tissues is Cox [5]. After absorbance of light, mito-
chondrial metabolism is modulated, promoting increases in
ATP synthesis as one of the secondary responses [5]. We sug-
gest that Bmuscle protection^ against exercise-induced dam-
age by LLLT is also a secondary response, but the connection
between the light absorption and this effect is not fully under-
stood. As a suggestion for future studies, we believe that
LLLT could possibly modulate the proteins of membrane
channels in muscle cells and/or in proteins involved in the
transduction of the mechanical stress generated during muscle
contraction involving the extracellular matrix and cytoskele-
ton. These modulations could improve the biochemical envi-
ronment and the mechanical response of the muscle cells to
exercise by stabilizing the muscle cell membrane.
It should be noted that there is no current position taken by
the World Anti-Doping Agency (WADA) or the International
Olympic Committee (IOC) regarding the use of LLLT for the
enhancement of muscle performance. However, if the use of
LLLT before athletic competition becomes widespread, we
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expect discussions will have to take place in the appropriate
circles on whether its use constitutes an unfair advantage.
Conclusion
Use of red and near-infrared LEDT for muscular pre-
conditioning was effective in the prevention of muscle dam-
age (CK) in professional volleyball players during official
matches. There was a therapeutic window (dose response)
for this effect with a better dose of 210–315 J applied over
the entire target muscles than with 0 J (placebo) or 105 J. Our
results will stimulate more researchers and teams of high-
performance sports to use LEDT for the prevention of muscle
damage in professional athletes.
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